Preventing Central Catheter-Associated Bloodstream Infections

Status Not yet recruiting

Clinical Trial Summary

The research is an algorithm study focused on nursing care in order to prevent Central Catheter-Associated Bloodstream Infections in intensive care units. The algorithm prepared with infection control measures related to central catheter care will be applied with intensive care nurses and the effect of the algorithm on central catheter-related bloodstream infections will be examined. In practice, a 20-day preliminary assessment, a three-month intervention period, and a three-month post-intervention planning were made.

Clinical Trial Description

In the light of literature review and guidelines, intensive care nurses will care for central catheters through an algorithm created with infection control measures. Nurse-focused algorithm content to prevent central catheter-related bloodstream infections Hand hygiene practice Use of personal protective equipment according to infection control measures Evaluation of the catheter insertion site in terms of redness, swelling, tenderness, discharge, bleeding Use of >0.5% chlorhexidine solution containing 70% alcohol for skin antisepsis at the catheter insertion site (if there is no chlorhexidine, povidone iodine + 70% alcohol solution is used) Changing the transparent, semi-permeable dressings every 5-7 days and gauze dressings every 48 hours for catheter dressing Catheter dressing with aseptic technique Use of sterile, preservative-free saline for flushing and locking in order to ensure the lumen of the catheter. Aseptic conditions should be observed if the junction of the catheter and the infusion set (Hub) is to be touched. Keeping the used triple taps closed Changing IV fluid sets and connection tools at appropriate times Daily assessment of CVC requirement The research will be carried out in the 1st, 2nd and 3rd Level Intensive Care Units of Bilecik Training and Research Hospital in Bilecik, Turkey. Infection rates will be compared in the study. In the study, the date of June 2021 will be taken as a preliminary assessment and training time for nurses. July-September 2021 will be the intervention period of the study, and October-December 2021 will be the post-intervention period. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04920877
Study type	Interventional
Source	Abant Izzet Baysal University
Contact
Status	Not yet recruiting
Phase	N/A
Start date	June 4, 2021
Completion date	December 31, 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05440396` - Identifying Local Signs at the Catheter Insertion Site With Artificial Intelligence
Recruiting	`NCT05729321` - Lock sOlutiOnS for Epicutaneo-caval Catheters in Neonates: a "LOOSEN" Pilot Study
Recruiting	`NCT06332040` - Gentamicin Bladder Instillation on CAUTI	Phase 4
Not yet recruiting	`NCT06019897` - Impact of Tubing Colonization on the Incidence of Central Venous Catheter Infection
Completed	`NCT03101371` - Reducing Urinary Tract Infection Rates Using a Controlled Aseptic Protocol for Catheter Insertion	Phase 2
Completed	`NCT03405038` - Prone Position Impact in ARDS Patients on the Incidence of Central Venous Catheter Colonization
Recruiting	`NCT05741866` - Novel Antimicrobial Dressing in Peripheral Intravenous Catheters (PIVCs)	N/A
Completed	`NCT06312215` - Effect Of Open And Closed System Peripheral Catheters Used In Pediatric Services	N/A
Recruiting	`NCT04825314` - Noble Meta Alloy Coated Catheters in Patients With Long Term Catheterization	N/A
Not yet recruiting	`NCT03914144` - Postnatal Prevalence of Bacteriuria in Women With Catheter Versus no Catheter in Labour: a Prospective Cohort Study
Not yet recruiting	`NCT03764358` - AUSTrian Randomized Interventional Study on Dialysis Accesses	N/A
Recruiting	`NCT03897959` - COMPARISON OF KOHLI AND FOLEY CATHETERS IN SUPRAPUBIC CATHETER PATIENTS	N/A
Terminated	`NCT03447639` - Betadine Bladder Irrigations vs. Standard of Care Prior to Indwelling Catheter Removal	Phase 4
Recruiting	`NCT04548713` - CLiCK in the Critical Care Unit	N/A
Recruiting	`NCT05931887` - Evaluation of the Novel Silq ClearTract Catheter in Patients With Chronic Urinary Retention	N/A
Completed	`NCT02599181` - Local Inflammation Does Not Correlate With Bacterial Colonization and Contamination of Perineural Catheters	N/A
Completed	`NCT03725293` - Midlines and Thrombophlebitis	N/A
Completed	`NCT06037525` - Clinical Evaluation of the PowerGlide™ Pro Midline Catheter
Completed	`NCT04772209` - Comparison of Effectiveness and Complications of Catheter Lock Solutions in Non-tunneled Hemodialysis Catheters	N/A
Withdrawn	`NCT01525498` - Foley Catheterization Following Sacrocolpopexy	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.